RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies

Am J Geriatr Psychiatry 18(9):801-809 · 2010 · PMID 20220577

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

542편 검색→520편 판독→117편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Total scores of the CERAD neuropsychological battery for detecting mild cognitive impairment and dementia (CERAD[tiab] OR "Consortium to Establish a Registry for Alzheimer's Disease"[tiab] OR "CERAD neuropsychological battery"[tiab]) AND ("neuropsychological tests"[MeSH Terms] OR "neuropsychological test*"[tiab] OR "neuropsychological battery"[tiab] OR "total score*"[tiab] OR "total scores"[tiab]) AND ("mild cognitive impairment"[MeSH Terms] OR "mild cognitive impairment"[tiab] OR "MCI"[tiab] OR dementia[MeSH Terms] OR dementia[tiab] OR "Alzheimer disease"[MeSH Terms])

출판 연도

1991: 2편219911992: 1편11994: 1편119951998: 1편11999: 2편220002001: 3편32002: 1편12003: 1편12005: 6편620052006: 3편32007: 2편22008: 1편12009: 6편62010: 6편620102011: 4편42012: 3편32013: 4편42014: 6편62015: 6편620152016: 5편52017: 2편22018: 7편72019: 6편62020: 4편420202021: 5편52022: 7편72023: 4편42024: 7편72025: 5편52026: 6편62026

선별된 117편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01specificity · sensitivity32편

  1. 0.96

    Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies 이 논문

    Seo EH, Lee DY, Lee JH et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2010

  2. 0.96

    The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy

    Wolfsgruber S, Jessen F, Wiese B et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2014

  3. 0.96

    CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study

    Paajanen T, Hanninen T, Tunnard C et al. · Journal of Alzheimer's disease : JAD · 2010

  4. 0.96

    Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene

    Aguirre-Acevedo DC, Jaimes-Barragan F, Henao E et al. · International psychogeriatrics · 2016

  5. 0.95

    A total score for the CERAD neuropsychological battery

    Chandler MJ, Lacritz LH, Hynan LS et al. · Neurology · 2005

  6. 0.95

    CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study

    Paajanen T, Hanninen T, Tunnard C et al. · Journal of Alzheimer's disease : JAD · 2014

  7. 0.94

    Early detection of Alzheimer's disease with a total score of the German CERAD

    Ehrensperger MM, Berres M, Taylor KI et al. · Journal of the International Neuropsychological Society : JINS · 2010

  8. 0.90

    Education-Based Cutoffs for Cognitive Screening of Alzheimer's Disease

    Alenius M, Ngandu T, Koskinen S et al. · Dementia and geriatric cognitive disorders · 2022

  9. 0.88

    Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals

    Muller S, Herde L, Preische O et al. · Scientific reports · 2019

  10. 0.85

    A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study

    Lillig R, Ophey A, Schulz JB et al. · Parkinsonism & related disorders · 2021

  11. 0.79

    CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease

    Karrasch M, Sinerva E, Gronholm P et al. · Acta neurologica Scandinavica · 2005

  12. 0.78

    The Japanese MCI screen for early detection of Alzheimer's disease and related disorders

    Cho A, Sugimura M, Nakano S et al. · American journal of Alzheimer's disease and other dementias · 2008

  13. 0.76

    Education-corrected CERAD identifies MCI and dementia in Parkinson's disease

    Karrasch M, Laatu S, Ellfolk U et al. · Acta neurologica Scandinavica · 2015

  14. 0.76

    Reliability and Validity of a Tablet-Based Neuropsychological Test (the Hellocog) for Screening Dementia RECODE

    Seok DH, Yang HW, Han JW et al. · Psychiatry investigation · 2024

  15. 0.73

    Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer's Disease

    Kwak S, Oh DJ, Jeon YJ et al. · Journal of Alzheimer's disease : JAD · 2022

  16. 0.73

    CERAD-neuropsychological battery in screening mild Alzheimer's disease

    Sotaniemi M, Pulliainen V, Hokkanen L et al. · Acta neurologica Scandinavica · 2012

  17. 0.73

    Cross-sectional assessment of telephone- and computer-administered instruments in detection of cognitive impairment

    Aaltonen A, Saari TT, Urjansson M et al. · Journal of clinical and experimental neuropsychology · 2026

  18. 0.72

    Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease?

    Zehnder AE, Blasi S, Berres M et al. · American journal of Alzheimer's disease and other dementias · 2007

  19. 0.70

    Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study

    Tunvirachaisakul C, Supasitthumrong T, Tangwongchai S et al. · Dementia and geriatric cognitive disorders · 2018

  20. 0.70

    Association of Plasma Oligomerized Beta Amyloid with Neurocognitive Battery Using Korean Version of Consortium to Establish a Registry for Alzheimer's Disease in Health Screening Population

    Lee JJ, Choi Y, Chung S et al. · Diagnostics (Basel, Switzerland) · 2020

  21. 0.69

    P300 and neuropsychological assessment in mild cognitive impairment and Alzheimer dementia

    Parra MA, Ascencio LL, Urquina HF et al. · Frontiers in neurology · 2012

  22. 0.66

    Methods to improve the detection of mild cognitive impairment

    Shankle WR, Romney AK, Hara J et al. · Proceedings of the National Academy of Sciences of the United States of America · 2005

  23. 0.62

    Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments

    Ophey A, Wolfsgruber S, Roeske S et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2021

  24. 0.61

    CERAD-NAB and flexible battery based neuropsychological differentiation of Alzheimer's dementia and depression using machine learning approaches

    Dominke C, Fischer AM, Grimmer T et al. · Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2024

  25. 0.58

    A nationwide survey on the prevalence of dementia and mild cognitive impairment in South Korea RECODE

    Kim KW, Park JH, Kim MH et al. · Journal of Alzheimer's disease : JAD · 2011

  26. 0.57

    Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease

    Costa AS, Reich A, Fimm B et al. · Dementia and geriatric cognitive disorders · 2014

  27. 0.57

    EEG theta and alpha reactivity on opening the eyes in the diagnosis of Alzheimer's disease

    Fonseca LC, Tedrus GMAS, Fondello MA et al. · Clinical EEG and neuroscience · 2011

  28. 0.56

    Informant Questionnaires in Dedicated Memory Clinics: How Much Do They Contribute?

    Novak L, Wyss P, Lenouvel E et al. · Journal of the American Geriatrics Society · 2021

  29. 0.53

    Association rule learning in neuropsychological data analysis for Alzheimer's disease

    Happawana KA, Diamond BJ · Journal of neuropsychology · 2022

  30. 0.53

    The Extension of the German CERAD Neuropsychological Assessment Battery with Tests Assessing Subcortical, Executive and Frontal Functions Improves Accuracy in Dementia Diagnosis

    Schmid NS, Ehrensperger MM, Berres M et al. · Dementia and geriatric cognitive disorders extra · 2014

  31. 0.53

    Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging

    Roalf DR, Moberg PJ, Xie SX et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013

  32. 0.50

    Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries RECODE

    Lee JH, Lee KU, Lee DY et al. · The journals of gerontology. Series B, Psychological sciences and social sciences · 2002

02function · older24편

  1. 0.77

    Moderation of Amyloid-beta Deposition on the Effect of Cholinesterase Inhibitors on Cognition in Mild Cognitive Impairment

    Byeon G, Byun MS, Yi D et al. · Journal of Alzheimer's disease : JAD · 2024

  2. 0.74

    A retrospective analysis of ultrasound neuromodulation therapy using transcranial pulse stimulation in 58 dementia patients

    Radjenovic S, Bender L, Gaal M et al. · Psychological medicine · 2025

  3. 0.74

    Dementia, cognitive impairment in Nigerians aged 90 years or older: A 20-year follow up of survivors of Ibadan study of aging cohort

    Baiyewu O, Elugbadebo O, Gao S et al. · International psychogeriatrics · 2026

  4. 0.71

    Effects of lifetime cumulative ginseng intake on cognitive function in late life RECODE

    Lho SK, Kim TH, Kwak KP et al. · Alzheimer's research & therapy · 2018

  5. 0.71

    Serum Homocysteine and Folate Levels are Associated With Late-life Dementia in a Korean Population

    Song JH, Park MH, Han C et al. · Osong public health and research perspectives · 2010

  6. 0.71

    Association of estimated white matter hyperintensity age with cognition in elderly with controlled hypertension RECODE

    Sung Kim J, Bin Bae J, Won Han J et al. · NeuroImage. Clinical · 2023

  7. 0.69

    Implications of helplessness in depression: diagnosing mild cognitive impairment and analyzing its effects on cognitive decline in older adults

    Lee BC, Choe YM, Suh GH et al. · Frontiers in aging neuroscience · 2024

  8. 0.63

    go4cognition: Combined Physiological and Cognitive Intervention in Mild Cognitive Impairment

    Lissek VJ, Ben Abdallah H, Praetorius A et al. · Journal of Alzheimer's disease : JAD · 2022

  9. 0.62

    go4cognition: Evaluation of a Newly Developed Multicomponent Intervention in Mild Cognitive Impairment

    Lissek VJ, Orth S, Suchan B · Journal of Alzheimer's disease : JAD · 2024

  10. 0.62

    Selenium and Episodic Memory: The Moderating Role of Apolipoprotein E epsilon4

    Kim SG, Keum M, Choe YM et al. · Nutrients · 2025

  11. 0.60

    Association of insulin resistance and health-related quality of life with mild cognitive impairment during aging

    Rotonen S, Auvinen J, Bloigu A et al. · Scandinavian journal of primary health care · 2026

  12. 0.59

    Estrogen receptor beta polymorphisms and cognitive performance in women: associations and modifications by genetic and environmental influences

    Fehsel K, Schikowski T, Janner M et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2016

  13. 0.59

    The Nordic diet and cognition--The DR's EXTRA Study

    Mannikko R, Komulainen P, Schwab U et al. · The British journal of nutrition · 2015

  14. 0.59

    Diabetes, glycaemia, and cognition-a secondary analysis of the Finnish Diabetes Prevention Study

    Lehtisalo J, Lindstrom J, Ngandu T et al. · Diabetes/metabolism research and reviews · 2016

  15. 0.58

    Effect of Tablet-based Cognitive Intervention on Cognition in Patients With Mild Cognitive Impairment: A Pilot Study

    Park JY, Choi SA, Kim JJ et al. · Dementia and neurocognitive disorders · 2023

  16. 0.57

    Cognitive reserve and the effects of virtual reality-based cognitive training on elderly individuals with mild cognitive impairment and normal cognition

    Kim H, Hong JP, Kang JM et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2021

  17. 0.57

    Connected-speech digital biomarkers for monitoring transcranial pulse stimulation in Alzheimer's disease: A pilot study

    Wiechmann D, Gunes A, Kerz E et al. · Journal of Alzheimer's disease : JAD · 2026

  18. 0.57

    Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment: a randomized controlled pilot trial

    Rita Cardoso B, Apolinario D, da Silva Bandeira V et al. · European journal of nutrition · 2016

  19. 0.56

    Genome-wide screen to identify genetic loci associated with cognitive decline in late-life depression

    Steffens DC, Garrett ME, Soldano KL et al. · International psychogeriatrics · 2024

  20. 0.55

    Effect of the NU-AGE Diet on Cognitive Functioning in Older Adults: A Randomized Controlled Trial

    Marseglia A, Xu W, Fratiglioni L et al. · Frontiers in physiology · 2018

  21. 0.54

    Association between physical activity and episodic memory and the moderating effects of the apolipoprotein E epsilon4 allele and age

    Lee BC, Choe YM, Suh GH et al. · Frontiers in aging neuroscience · 2023

  22. 0.54

    Multistrain probiotics modulate tau pathology and preserve visuospatial cognition in early cognitive impairment: A double-blind, randomized, placebo-controlled trial

    Seo EH, Kang S, Kim SG et al. · Journal of Alzheimer's disease : JAD · 2026

  23. 0.52

    Is ApoE epsilon4 associated with cognitive functioning in African Americans diagnosed with Alzheimer Disease? An exploratory study

    Mount DL, Ashley AV, Lah JJ et al. · Southern medical journal · 2009

  24. 0.50

    Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin

    Blasko I, Knaus G, Weiss E et al. · Journal of psychiatric research · 2007

03word list · recall20편

  1. 0.78

    In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits

    Tangwongchai S, Supasitthumrong T, Hemrunroj S et al. · Molecular neurobiology · 2018

  2. 0.74

    Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?

    Camargo CHF, Bronzini A, Tolentino EdS et al. · Arquivos de neuro-psiquiatria · 2018

  3. 0.72

    Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease

    Welsh KA, Butters N, Hughes JP et al. · Archives of neurology · 1992

  4. 0.71

    Development and validation of the Memory Performance Index: reducing measurement error in recall tests

    Shankle WR, Mangrola T, Chan T et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2009

  5. 0.68

    Detection of prospective memory deficits in mild cognitive impairment of suspected Alzheimer's disease etiology using a novel event-based prospective memory task

    Blanco-Campal A, Coen RF, Lawlor BA et al. · Journal of the International Neuropsychological Society : JINS · 2009

  6. 0.68

    Applicability of the CERAD neuropsychological battery to Brazilian elderly

    Bertolucci PH, Okamoto IH, Brucki SM et al. · Arquivos de neuro-psiquiatria · 2001

  7. 0.67

    Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study

    Vila-Castelar C, Guzman-Velez E, Pardilla-Delgado E et al. · Journal of Alzheimer's disease : JAD · 2020

  8. 0.65

    Development of a Brief Cognitive Screen for Mild Cognitive Impairment and Neurocognitive Disorder

    Woodard JL, Dorsett ESW, Cooper JG et al. · Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition · 2005

  9. 0.64

    Memory testing in dementia: how much is enough?

    Derrer DS, Howieson DB, Mueller EA et al. · Journal of geriatric psychiatry and neurology · 2001

  10. 0.63

    CERAD test performance and cognitive impairment in Parkinson's disease

    Karrasch M, Laatu S, Martikainen K et al. · Acta neurologica Scandinavica · 2013

  11. 0.62

    Neuropsychological study of familial Alzheimer's disease caused by mutation E280A in the presenilin 1 gene

    Arango Lasprilla JC, Iglesias J, Lopera F · American journal of Alzheimer's disease and other dementias · 2003

  12. 0.53

    The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease

    Kunig G, Jager M, Stief V et al. · International journal of geriatric psychiatry · 2006

  13. 0.53

    Certainty-weighted recognition memory: Potential applications for early detection and metacognition

    Harris M, Bateman JR, Shaaban CE et al. · Journal of Alzheimer's disease : JAD · 2026

  14. 0.53

    Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures

    Welsh K, Butters N, Hughes J et al. · Archives of neurology · 1991

  15. 0.52

    The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease

    Nerg O, Junkkari A, Hallikainen I et al. · Journal of Alzheimer's disease : JAD · 2021

  16. 0.51

    False recognition helps to distinguish patients with Alzheimer's disease and amnestic MCI from patients with other kinds of dementia

    Hildebrandt H, Haldenwanger A, Eling P · Dementia and geriatric cognitive disorders · 2009

  17. 0.51

    Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis

    Diehl J, Monsch AU, Aebi C et al. · Journal of geriatric psychiatry and neurology · 2005

  18. 0.51

    Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease

    Maurano STP, da Silva DJ, Avila MP et al. · International ophthalmology · 2018

  19. 0.50

    Late preterm birth and neurocognitive performance in late adulthood: a birth cohort study

    Heinonen K, Eriksson JG, Lahti J et al. · Pediatrics · 2015

  20. 0.50

    Learning characteristics of the CERAD word list in an elderly VA sample

    Jones SN, Greer AJ, Cox DE · Applied neuropsychology · 2011

04normative · education11편

  1. 0.91

    Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites

    Potter GG, Plassman BL, Burke JR et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2009

  2. 0.79

    Performance on the CERAD neuropsychology battery of two samples of Japanese-American elders: norms for persons with and without dementia

    Fillenbaum GG, McCurry SM, Kuchibhatla M et al. · Journal of the International Neuropsychological Society : JINS · 2005

  3. 0.60

    A normative study of total scores of the CERAD neuropsychological assessment battery in an educationally diverse elderly population RECODE

    Han JY, Seo EH, Yi D et al. · International psychogeriatrics · 2014

  4. 0.54

    Clinical utility of CERAD neuropsychological battery in elderly Jamaicans

    Unverzagt FW, Morgan OS, Thesiger CH et al. · Journal of the International Neuropsychological Society : JINS · 1999

  5. 0.54

    Comparison between two tests of delayed recall for the diagnosis of dementia

    Takada LT, Caramelli P, Fichman HC et al. · Arquivos de neuro-psiquiatria · 2006

  6. 0.53

    Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB)

    Mistridis P, Egli SC, Iverson GL et al. · European archives of psychiatry and clinical neuroscience · 2015

  7. 0.52

    Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery

    Fillenbaum GG, Heyman A, Huber MS et al. · Journal of the International Neuropsychological Society : JINS · 2001

  8. 0.51

    Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations

    Collie A, Shafiq-Antonacci R, Maruff P et al. · The Australian and New Zealand journal of psychiatry · 1999

  9. 0.51

    The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery

    Welsh KA, Butters N, Mohs RC et al. · Neurology · 1994

  10. 0.51

    Cognitive decline and education in mild dementia

    Unverzagt FW, Hui SL, Farlow MR et al. · Neurology · 1998

  11. 0.50

    Effects of age, gender, and education on cognitive tests in a rural elderly community sample: norms from the Monongahela Valley Independent Elders Survey

    Ganguli M, Ratcliff G, Huff FJ et al. · Neuroepidemiology · 1991

05csf · cerebrospinal fluid10편

  1. 0.87

    A Comparison of Operational Definitions for Mild Cognitive Impairment

    Polcher A, Wolfsgruber S, Peters O et al. · Journal of Alzheimer's disease : JAD · 2022

  2. 0.84

    Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline

    Stark M, Wolfsgruber S, Kleineidam L et al. · Neurology · 2023

  3. 0.67

    Neuropsychological Testing and Machine Learning Distinguish Alzheimer's Disease from Other Causes for Cognitive Impairment

    Gurevich P, Stuke H, Kastrup A et al. · Frontiers in aging neuroscience · 2017

  4. 0.66

    Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease

    Christl J, Verhulsdonk S, Pessanha F et al. · Journal of Alzheimer's disease : JAD · 2019

  5. 0.62

    Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers

    Park MK, Ahn J, Kim YJ et al. · Cells · 2024

  6. 0.54

    Cerebrospinal Fluid Biomarkers and Neuropsychological Abnormalities in Dementia: A Monocentric Study of Consecutive Patients

    Romer M, Lange-Asschenfeldt C, Muller-Schmitz K et al. · Journal of clinical medicine · 2025

  7. 0.53

    Low Cerebrospinal Fluid Amyloid-Beta Concentration Is Associated with Poorer Delayed Memory Recall in Women

    Haapalinna F, Paajanen T, Penttinen J et al. · Dementia and geriatric cognitive disorders extra · 2016

  8. 0.51

    Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease Continuum

    Menne F, Schipke CG, Klostermann A et al. · Journal of Alzheimer's disease : JAD · 2020

  9. 0.51

    Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease

    Haldenwanger A, Eling P, Kastrup A et al. · Journal of Alzheimer's disease : JAD · 2010

  10. 0.50

    Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease

    Supasitthumrong T, Tunvirachaisakul C, Aniwattanapong D et al. · Journal of Alzheimer's disease : JAD · 2019

06scale · rating10편

  1. 0.72

    Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study

    Hallikainen I, Koivisto AM, Paajanen T et al. · Dementia and geriatric cognitive disorders extra · 2012

  2. 0.72

    Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study

    Hallikainen I, Hanninen T, Fraunberg M et al. · International psychogeriatrics · 2013

  3. 0.72

    The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease

    Rossetti HC, Munro Cullum C, Hynan LS et al. · Alzheimer disease and associated disorders · 2010

  4. 0.72

    Dementia and mild cognitive impairment in patients with Parkinson's disease

    Tedrus GMAS, Fonseca LC, Letro GH et al. · Arquivos de neuro-psiquiatria · 2009

  5. 0.69

    Sustained effects of once-daily memantine treatment on cognition and functional communication skills in patients with moderate to severe Alzheimer's disease: results of a 16-week open-label trial

    Schulz JB, Rainer M, Klunemann HH et al. · Journal of Alzheimer's disease : JAD · 2011

  6. 0.62

    The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study

    Hallikainen I, Martikainen J, Lin PJ et al. · Dementia and geriatric cognitive disorders extra · 2014

  7. 0.60

    Cognitive Stimulation for Individuals with Parkinson's Disease Dementia Living in Long-Term Care: Preliminary Data from a Randomized Crossover Pilot Study

    Folkerts AK, Dorn ME, Roheger M et al. · Parkinson's disease · 2018

  8. 0.53

    Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study

    Tormalehto SM, Martikainen JA, Vaatainen ST et al. · Journal of Alzheimer's disease : JAD · 2015

  9. 0.50

    Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease: A Randomized Clinical Trial

    Matt E, Mitterwallner M, Radjenovic S et al. · JAMA network open · 2025

  10. 0.50

    Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria

    Kern D, Khalil M, Pirpamer L et al. · Medicina (Kaunas, Lithuania) · 2022

07brain · imaging9편

  1. 0.85

    CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease

    Paajanen T, Hanninen T, Aitken A et al. · Dementia and geriatric cognitive disorders extra · 2013

  2. 0.70

    Brain Amyloid Index as a Probable Marker Bridging Between Subjective Memory Complaint and Objective Cognitive Performance

    Choe YM, Suh GH, Lee BC et al. · Frontiers in neuroscience · 2022

  3. 0.70

    Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia

    Choi M, Youn H, Kim D et al. · PloS one · 2019

  4. 0.69

    Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer's disease and FDG-PET findings

    Hsu JL, Hsu WC, Chang CC et al. · Scientific reports · 2017

  5. 0.61

    Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease

    Bilello M, Doshi J, Nabavizadeh SA et al. · Journal of Alzheimer's disease : JAD · 2015

  6. 0.58

    Correlation of early-phase beta-amyloid positron-emission-tomography and neuropsychological testing in patients with Alzheimer's disease

    Volter F, Eckenweber S, Scheifele M et al. · European journal of nuclear medicine and molecular imaging · 2025

  7. 0.56

    Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography

    Perneczky R, Drzezga A, Diehl-Schmid J et al. · Journal of neurology, neurosurgery, and psychiatry · 2006

  8. 0.55

    Structural brain signature of cognitive decline in Parkinson's disease: DTI-based evidence from the LANDSCAPE study

    Gorges M, Muller HP, Liepelt-Scarfone I et al. · Therapeutic advances in neurological disorders · 2019

  9. 0.50

    Orthostatic hypotension as a risk factor for longitudinal deterioration of cognitive function in the elderly

    Zimmermann M, Wurster I, Lerche S et al. · European journal of neurology · 2020

08pathology · braak1편

  1. 0.59

    Cognitive Effects of White Matter Pathology in Normal and Pathological Aging

    Kaskikallio A, Karrasch M, Rinne JO et al. · Journal of Alzheimer's disease : JAD · 2019